You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
CTDetailNew
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Appointment
Find a Condition or Treatment
Find a Doctor
Menu
MAIN
Back to Home
About Us
Corporate Profile
Newsroom
Events
Procurement
Contact Us
Patient Care
Conditions & Treatments
Specialties & Services
Find a Doctor
Your Clinic Visit
Visitor Information
E-services
Research & Innovation
Research Platforms
Researchers
Laboratories
Clinical Trials & Research
Publications
SingHealth Research
Neurocognitive Research & Clinical Centre (NNRC)
Education & Training
Residency
Health Professional Education
Fellowships
SingHealth Academy
Careers
Why Choose Us
Career Choices
Scholarships & Sponsorships
Job Opportunities
Contact Us
Giving
Why Give
Get Involved
Your Gift at Work
Be Informed
Make a Gift
Conditions & Treatments
Back to Home
Find a Condition
Find a Medicine
Patient Education Brochures
教育手册
Health Apps
Memory Care
Parkinson's Care
Stroke Buddy
Specialties & Services
Back to Home
Clinical Specialties
Neurology
Neurosurgery
Diagnostic Radiology (Neuroradiology)
Neurodiagnostic Laboratory
Neuromuscular Laboratory
Programmes
NNI-Community Health Programme
Temasek Foundation-NNI Stroke Memory Rehabilitation (SMaRT) Programme
淡马锡基金会 - 新加坡国立脑神经医学院中风后记忆康复 (SMaRT) 课程
Temasek Foundation Parkinson's Disease Community Care Programme
Video & Phone Consultation
Drop and Go
PillDeliver
Find a Doctor
Your Clinic Visit
Back to Home
Your Clinic Visit
Getting to NNI
Getting around NNI@TTSH
Make or Change Appointment
Consultation Charges
Billing & Payment
Visitor Information
Back to Home
Advisory: COVID-19 & MERS
Getting to NNI
Neuroscience Clinic (NSOC) at NNI@TTSH
Neuroradiology (NRD) at NNI@TTSH
Neurodiagnostic Laboratory (NDL) at NNI@TTSH
Patient Support Groups
NNI Virtual Tour
Contact Us
E-services
Back to Home
Make/Change/Cancel Appointment
Home
to skip to the main content on a page
to skip to the main content on a page
About Us
Back to Home
Corporate Profile
Our Vision and Mission
Our History
Chief Executive Officer's Office
Our Services
Newsroom
News Release
News Articles
Publications
NeusLink
Events
Procurement
Contact Us
Submit Enquiry, Feedback or Compliment
Check Fake News
Patient Care
Back to Home
Conditions & Treatments
Find a Condition
Find a Medicine
Patient Education Brochures
教育手册
Health Apps
Specialties & Services
Clinical Specialties
Programmes
Video & Phone Consultation
Drop and Go
PillDeliver
Find a Doctor
Your Clinic Visit
Your Clinic Visit
Make or Change Appointment
Consultation Charges
Billing & Payment
Visitor Information
Advisory: COVID-19 & MERS
Getting to NNI
Patient Support Groups
NNI Virtual Tour
Contact Us
E-services
Make/Change/Cancel Appointment
Research & Innovation
Back to Home
Research Platforms
ASEAN Microbiome Nutrition Centre (AMNC)
BioNeuro-Computing
Genomics
Regenerative Medicine
NNI Special Signature Programme
Researchers
Research Director's Message
Laboratories
Calcium Signalling Laboratory
Neural Stem Cell Research Laboratory
Neurodegeneration Laboratory
Neuro-Oncology Research Laboratory
Molecular Neurotherapeutics Laboratory
Parkinson’s Disease & Movement Disorders Translational Research Laboratory
Translational Therapeutics Laboratory
Clinical Trials & Research
Publications
SingHealth Research
Neurocognitive Research & Clinical Centre (NNRC)
Education & Training
Back to Home
Residency
Health Professional Education
Neurology Education
Neurosurgery Education
Neuroradiology Education
Neuroscience Nursing Education
Fellowships
SingHealth Academy
Careers
Back to Home
Why Choose Us
Benefits
Health & Wellness
Appreciation & Recognition
Fun & Recreation
Professional Development
Career Choices
Scholarships & Sponsorships
Job Opportunities
Contact Us
Giving
Back to Home
Why Give
About NNI Fund
Patient Care
Innovative Research
Advanced Medical Education
Get Involved
Make a Gift
Be a Corporate Partner
Join our Events
Past Events
Our Thanks
Your Gift at Work
Meet Grateful Patients
Meet Our Researchers
Meet Staff Donors
Be Informed
Giving Reports
Make a Gift
NNI Fund
Home
>
Patient Care
>
Conditions and Treatment
>
Multiple Myeloma
>
Treatment
Facebook
WhatsApp
Email Us
share
Font Resize
A-
A
A+
Print
Multiple Myeloma
Multiple Myeloma - Treatments
SGH is a comprehensive myeloma care centre. At SGH, you'll receive care from a team of doctors and nurses who work together to understand and offer you personalised care.
Treatment for myeloma depends on age, patient’s fitness or frailty at the time of diagnosis, presence, or absence of other medical issues like kidney failure, nerve damage symptoms etc.
Treatment of Myeloma:
All patients diagnosed with myeloma benefit from treatment as it can help relieve pain, control and minimize complications of the disease, stabilize your condition and slow the progress of multiple myeloma.
While myeloma is not a curable condition, there are many treatment options which are effective in controlling the disease for years.
The goal of treatment is to bring myeloma in to a good remission and to keep it there for as long as possible while preventing and minimizing its complications and ultimately improve the quality of life.
Treatment of myeloma can be divided into different phases:
Induction Phase: with the aim to reduce the amount of cancer cells in the bone marrow
Consolidation Phase: with the aim of further deepen the response after induction therapy using treatments like an autologous haematopoietic stem cell transplant
Maintenance Phase
There are different treatment modalities used in treatment of myeloma. They are often used in combination and is tailored based on the patient’s disease characteristics and overall function.
Corticosteroids:
Steroids can regulate the immune system and can control inflammation in the body. They are also very active against myeloma cells.
Chemotherapy
:
There are many chemotherapy drugs that are used to eradicate myeloma cancer cells and prevent their growth. There are different group of chemotherapy drugs used to treat myeloma: proteasome inhibitors, alkylators, immunomodulatory drugs etc.
Immunotherapy:
Immunotherapy harnesses the power of your immune system to control myeloma. For example, monoclonal antibodies like daratumumab target a specific protein on the surface of cancerous plasma cells and make it easier for the immune cells to identify and kill them.
Haematopoietic Stem Cell Transplantation:
Stem cell Transplantation involves the substitution of diseased bone marrow with healthy bone marrow stem cells. In most cases, the patient’s healthy stem cells are transplanted. Healthy blood-forming stem cells are collected from the patient by a process called apheresis and is stored in advance of the transplantation. During transplantation, high doses of chemotherapy drugs are then given to destroy the diseased bone marrow. This isfollowed by reinfusion of previously collected stem cells back into the blood which then home in on the bone marrow and start producing all blood and immune cells
Radiation therapy:
Radiation therapy or radiotherapy uses high-energy radiation (rays or particles) to kill or damage cancer cells. It is usually used to shrink localised collection of cancerous plasma cells that form a tumor and is commonly used in combination with chemoimmunotherapy.
The management of multiple myeloma requires a multi-disciplinary team to support patients in various aspects of their care. We have a dedicated pharmacist-led education and medication reconciliation service, transplant and cell therapy co-ordinators and robust patient education supported by our advanced practice nurses. Our dedicated medical social workers also facilitate the provision of financial and psychosocial support to patients.
SGH also has many clinical trials that are specifically designed for and beneficial to myeloma patients. By collaborating with other institutions and industry partners in Singapore, South Asia and globally, we aim to continue bringing novel treatment options to Singapore myeloma patients via clinical trials.
Multiple Myeloma - Preparing for surgery
Multiple Myeloma - Post-surgery care
Multiple Myeloma - Other Information
Display Entire Article +
Diagnosis
Tags:
Haematology,
Blood Cancer,
Chemotherapy,
Bortezomib,
Carfilzomib,
Corticosteroid,
Cyclophosphamide,
Daratumumab,
Dexamethasone,
Ixazomib,
Lenalidomide,
Melphalan,
Pomalidomide,
Thalidomide
Article contributed by
Haematology
,
Singapore General Hospital
The information provided is not intended as medical advice.
Terms of use
. Information provided by
Our Breast Team
Filter:
By designation or sub-specialty
By Designation:
By Sub-Specialty:
TOP
[]
Related Conditions
Blood Cancer
Chemotherapy
View more
Related Medicine
Corticosteroid
Dexamethasone
Bortezomib
Carfilzomib
Ixazomib
Thalidomide
Lenalidomide
Pomalidomide
Daratumumab
Cyclophosphamide
Melphalan
View more
Healthy Living Tips
by
View more
Discover articles,videos, and guides afrom Singhealth's resources across the web. These information are collated, making healthy living much easier for everyone.
What to Eat Before, During and After a Marathon
Popular Food and Eating Myths Busted
Diabetes Tips - How to Exercise Safely
Diet Tips to Lower Blood Pressure
My Health Tools
Request/ Change appointment
Find a Specialist
×
SUBCRIBE VIA EMAIL
Subcribe to our mailing list to get the updates to your email inbox...
Find a Doctor
Conditions & Treatments
Home
Appointments
E-services